AzTrials
AzTrials

Eating, Time RestrictedNCT06541392

The Efficacy of Proper Breakfast Times on Cognitive Function

A study testing breakfast 6.30 am and breakfast 7.31 am in people with Eating, Time Restricted and Cognitive Change, run by University of Muhammadiyah Aceh.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this cluster randomized controlled trial is to learn if a proper breakfast time may increase cognitive function. It will also learn about the effectiveness of proper breakfast time on health outcomes. Read more about this study

Who is it for?
Ages 18 to 24 yearsHealthy volunteers can take part
What is being tested?
breakfast 6.30 am and breakfast 7.31 am
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
15 Aug 2024to 30 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Active student in the year 2024
  • Not in medication
  • Do not have gastritis or any diseases that require to have breakfast earlier in the morning
  • Willing to sign an informed consent
  • Have health insurance

Who cannot join

  • Abstain in the education session
  • Having emotional and mental health problems
  • Students in the final class who are undergoing the thesis writing

Trial locations and contacts

No sites are listed yet.

Dharina Baharuddin, MPH contact

+6285260963094

dharinabaharuddin@gmail.com

Maidar Abdul Manan, Ph.D contact

+628126439913

maidar7117@gmail.com

About this study

Official title: The Effectiveness of Proper Breakfast Times on Cognitive Function and Health Outcomes Among College Students

The goal of this cluster randomized controlled trial is to learn if a proper breakfast time may increase cognitive function. It will also learn about the effectiveness of proper breakfast time on health outcomes. The main questions it aims to answer are:

Does a proper breakfast time increase cognitive function and health outcomes?

Participants will:

  • wake up in the morning at 6 o'clock
  • Having breakfast at 6.30 - 7.30 am or 7.31-8.31 am, or having breakfast time according to their wishes.
  • Having lunch started at 12.00 pm.
Read the detailed description

This experimental study uses a Cluster Randomized Controlled Trial non-blinding parallel method design. The objective of this study is to assess the effectiveness of proper breakfast time on cognitive function including the focus on learning and mood among university students. Additionally, the study determines health outcomes such as heart rate, systolic blood pressure, diastolic blood pressure, and macro and micronutrient intake. There are a total of 60 participants from three different faculties. All faculties will be randomly selected and assigned to intervention group 1, intervention group 2, and the control group. Each group consists of 20 participants from each faculty in the university. Intervention Group 1 will have breakfast from 6:30 to 7:30 am, and Intervention Group 2 from 7:31 to 8:31 am. Meanwhile, the control group will continue their preferred breakfast routine. The intervention groups are required to wake up at 6:00 am and have lunch at 12:00 pm.

Being tested
breakfast 6.30 am, breakfast 7.31 am
Medical subject headings
Intermittent Fasting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • breakfast 6.30 amOther

    This group will have breakfast time from 6.30 to 7.30 am

  • breakfast 7.31 amOther

    This group will have breakfast time from 7.31 to 8.31 am

Study groups in NCT06541392
Study groupRoleWhat they receive
Breakfast1ExperimentalThis group will have breakfast time at 6.30 to 7.30 am
Receives: Other: breakfast 6.30 am
Breakfast2ExperimentalThis group will have breakfast time from 7.31 am to 8.31 am
Receives: Other: breakfast 7.31 am
ControlNo interventionThis group will have breakfast time according to their wishes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Focus

    To determine the changes in focus between the groups using the Army alpha test

    Measured: 8 weeks

  2. Mood

    To determine the changes in mood between the groups using the profile of moods state (POMS) questionnaire

    Measured: 8 weeks

Secondary outcomes (5)
  1. Systolic blood pressure

    To determine the changes in systolic blood pressure between the groups using the sphygmomanometer

    Measured: 8 weeks

  2. Diastolic blood pressure

    To determine the changes in diastolic blood pressure between the groups using the sphygmomanometer

    Measured: 8 weeks

  3. Heart rate

    To determine the changes in heart rate between the groups using the sphygmomanometer

    Measured: 8 weeks

  4. macro nutrition intake

    To determine the changes in macro nutrition intake between the groups using the 3-day food record

    Measured: 8 weeks

  5. micro-nutrition

    To determine the changes in micro-nutrition intake between the groups using the 3-day food record

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2024
  2. Study start15 Aug 2024 (estimated)
  3. Primary completion30 Dec 2024 (estimated)
  4. Study completion30 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06541392
Sponsor's protocol ID
LP4MRiset
Status last verified
Aug 2024
First submitted
30 Jul 2024
Last updated
7 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Moreno-Aznar LA, Vidal Carou MDC, Lopez Sobaler AM, Varela-Moreiras G, Moreno Villares JM. [Role of breakfast and its quality in the health of children and adolescents in Spain]. Nutr Hosp. 2021 Apr 19;38(2):396-409. doi: 10.20960/nh.03398. Spanish.

    PubMed 33724048
  • Baharuddin D, Said MA, Majid HA. Protocol For Intervention Study In Reducing Elevated Blood Pressure Through Intermittent Fasting. J Pak Med Assoc. 2023 Nov;73(11):2171-2176. doi: 10.47391/JPMA.7748.

    PubMed 38013523
  • Crabtree DR, Holliday A, Buosi W, Fyfe CL, Horgan GW, Johnstone AM, On Behalf Of The Full Health-Study Group. The Acute Effects of Breakfast Drinks with Varying Protein and Energy Contents on Appetite and Free-Living Energy Intake in UK Older Adults. Geriatrics (Basel). 2022 Jan 30;7(1):16. doi: 10.3390/geriatrics7010016.

    PubMed 35200521
  • Dalgaard LB, Kruse DZ, Norup K, Andersen BV, Hansen M. A dairy-based, protein-rich breakfast enhances satiety and cognitive concentration before lunch in overweight to obese young females: A randomized controlled crossover study. J Dairy Sci. 2024 May;107(5):2653-2667. doi: 10.3168/jds.2023-24152. Epub 2023 Dec 21.

    PubMed 38135050
  • Xian X, Wang C, Yu R, Ye M. Breakfast Frequency and Sleep Quality in College Students: The Multiple Mediating Effects of Sleep Chronotypes and Depressive Symptoms. Nutrients. 2023 Jun 8;15(12):2678. doi: 10.3390/nu15122678.

    PubMed 37375582

Questions about this trial

What is this clinical trial studying?

A study testing breakfast 6.30 am and breakfast 7.31 am in people with Eating, Time Restricted and Cognitive Change, run by University of Muhammadiyah Aceh.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dharina Baharuddin, MPH (+6285260963094, dharinabaharuddin@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Focus (time frame: 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06541392, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in